The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for December 14, 2018
Copyright © Brakke Consulting, Inc.

Editor: Lynn Fondon DVM MBA

Brakke Consulting news
US Flea Control & Heartworm Markets report NOW AVAILABLE
2019 Industry Overview – registration is now open
Market research services

earnings news
ECO Animal Health Group

other news
American Veterinary Distributors Association
BC Partners
Boehringer Ingelheim
BPV Environmental
Evonik Industries
Global Stem Cell Technology
Hallmarq Veterinary Imaging
Jayhawk Fine Chemicals
Kane Biotech
Pestell Group
United Veterinary Services Association
Vetology Innovations
Vetoquinol USA


Are you on top of the trends in the largest market segment in companion animal health? Brakke Consulting’s 2018 report on the US Flea Control and Heartworm Markets can give you the most up-to-the-minute information on this dynamic market segment.

The report includes valuable information on the US market for small animal parasiticides including:
– Product descriptions, prices, and sales for the leading veterinary flea, tick and heartworm products
– an overview of the veterinary and OTC flea control markets
– discussion of new flea and tick products including CREDELIO and CENTRAGARD
– 2018 survey of 360 veterinarians
– 2018 survey of 500 pet owners

The report on the US Flea Control & Heartworm Markets is available immediately for a purchase price of $7,750.

Please contact Dr. Lynn Fondon at to order the report, or for more information visit our website.


• ECO Animal Health Group plc reported results for the six months ended September 30, 2018. Sales were GBP 31.7 million ($41.3 million), an increase of 9% compared to the comparable prior-year period (+11% at constant exchange rate). Earnings before interest, tax, depreciation, amortization, share based payments and non-controlling (minority) interests were GBP 8.6 million ($11.2 million), an increase of 5%. (company press release)


Brakke Consulting is pleased to announce the 2019 Industry Overview. The 2019 Animal Health Industry Overview will be presented twice this winter – once at the VMX in Orlando, Florida and once at the Western Veterinary Conference in Las Vegas, Nevada. These dates are:

• VMX: Tuesday, January 22, 2019, 2:00 – 4:00 pm, Rosen Plaza Hotel
• WVC: Tuesday, February 19, 2019, 2:00 – 4:00 pm, Four Seasons.

Registration for the VMX & WVC Industry Overviews is now open. Seating is limited this year, so register early!

To register, go to and scroll down to the “What’s New” box. The price is $400 per person for online registration; late registration is $450. Discounts are available for multiple attendees from the same company; visit our website or call 972-243-4033 for more information.


• Merck announced that it has signed a definitive agreement to acquire Antelliq, a leader in digital animal identification, traceability and monitoring solutions, from funds advised by BC Partners. Antelliq had EUR 360 million euros ($409 million) in sales in the 12-month period ending September 30, 2018. Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health Division. Merck will make a cash payment of approximately EUR 2.1 billion ($2.4 billion) to acquire all outstanding shares of Antelliq and will assume Antelliq’s debt of EUR 1.15 billion, which it intends to repay shortly after the closing of the acquisition. (company press release)

• Elanco Animal Health announced it will implement a year-long restructuring plan that will include job cuts, citing the need to shift its focus and resources to priority areas. It will record a $37 million charge this quarter, comprised of $19 million in severance costs and $18 million in asset write-offs. Total cash costs should be approximately $20 million. (

• Bayer Animal Health announced a global license agreement with ParaTheraTech (PTT) to develop a cryptosporidiosis treatment for food-producing animals. Bayer will develop and commercialize novel compounds based on intellectual property licensed by PTT from the University of Washington. (Animal Pharm)

• Vetoquinol USA announced the launch of pH-notix, an ear cleaner and wax remover for cats & dogs that delivers advanced ceruminolytic action, assistance with sebum regulation, and support for the restoration of the skin acid mantle. (company announcement)

• ImmuCell Corporation announced that the USDA has issued a product license for Dual-Force First Defense. Dual-Force in a single-dose oral syringe provides guaranteed levels of E. coli and coronavirus antibodies to prevent scours in newborn calves. The product offers a non-digestible blue dye that serves as a marker, turning the calf’s first stool after administration neon blue-green to help detect and prevent protocol drift. (company press release)

• Kane Biotech Inc. announced it will be launching 4 new products under its bluestem brand in Canada and the US in the first quarter of 2019: a powder water additive, dental wipe, and two sizes of dental chew. All of the new products are formulated with Kane Biotech’s patent-pending coactiv+ technology. (company press release)

• Pestell Group announced it has acquired BPV Environmental, a manufacturer of alternative paper-based animal litter, small animal bedding, and lawn and garden products. Financial terms were not disclosed. (Pet Product News)

• Vetology Innovations, LLC, announced the debut of Vetology AI, the veterinary industry’s first radiology-focused artificial intelligence (AI) solution. Vetology AI provides veterinary professionals with automated diagnostic analysis of patient radiographs. (

• Petco announced it has partnered with Yantriks’ Personalized Fulfillment Platform (PFP) to deliver “buy online pick up in-store” (BOPUS) capabilities to their online customers. (Pet Product News)

• Amazon announced it is working with VCA Animal Hospitals to provide voice command technology to pet owners that will enable VCA account holders to receive pet healthcare reminders and book appointments through Amazon Alexa. VCA is reportedly the first animal hospital industry to introduce voice command technology. (Animal Pharm)

• Permira announced it has acquired Jayhawk Fine Chemicals, a custom manufacturer of specialty chemicals used in pharmaceuticals, animal health, agriculture and consumer electronics, from Evonik Industries. Financial terms were not disclosed. (Animal Pharm)

• McDonald’s announced a new policy for beef that commits to reducing by end of 2020 the overall use of antibiotics important to human health, as defined by the World Health Organization (WHO), for medically important antibiotics in its 10 beef sourcing markets. In a similar move, Costco announced it is working with its meat and poultry suppliers to restrict use of antibiotics that are medically important to humans, with a target date of December 2020 for suppliers to comply with the new policy. (Feedstuffs, Animal Pharm)

• The American Veterinary Distributors Association announced a name change to The United Veterinary Services Association (UVSA) to more appropriately reflect the new direction of the association. The USVA’s new mission is “as the hub for relevant information leading to innovation in the supply chain, AVDA will enhance animal care by supporting those who serve the veterinary channel.” (association press release)

• EU Boehringer Ingelheim Animal Health announced it has signed an exclusive European distribution deal with Global Stem Cell Technology (GST) for Arti-Cell Forte, a stem cell product based on specially primed horse-blood-derived stem cells. The product’s intended indication is the reduction of mild-to-moderate recurrent lameness associated with non-septic joint inflammation in horses. Arti-Cell Forte received a landmark positive opinion in June 2018; the product is still awaiting full approval from the European Medicines Agency. (Animal Pharm)

• COLOMBIA Neovia announced it has acquired Colombian premix company Biomix. Founded in 1999, Biomix is the third-largest player in premix and services in the Colombian market. The company is mainly active in poultry but also offers solutions for other species such as pork and ruminants. Financial terms were not disclosed. (Feed Strategy enews)

• FRANCE Alivira announced the launch in France of Moxiclear (generic imidacloprid + moxidectin), a spot-on for cats used for the treatment of management of infestations by fleas, intestinal worms and heartworms. (company announcement)

• UK August Equity announced it has supported the management buyout (MBO) of Hallmarq Veterinary Imaging Ltd. Financial terms were not disclosed. Hallmarq developed the world’s only MRI scanner for the standing horse as well as PetVet, an MRI system specifically designed for the anatomy of dogs and cats. (

• IRELAND TERRA NutriTECH, a company specializing in technology and automation to accurately feed minerals in water to livestock, announced it will invest EUR 2 million (US$2.3 million) to expand its global operations. The company will use the investment for research and development and to grow its staff. (Feed Strategy enews)

• CANADA XpertSea announced it has launched a platform that automates data collection and provides real-time insights for the aquaculture industry. The XpertSea Growth Platform is available for farms and hatcheries for both shrimps and fish and is currently deployed in more than 250 sites in Ecuador, Mexico, the UK, Vietnam, India, Indonesia, Thailand, Brazil and China. (Animal Pharm)


• JAPAN – CSF Animal health authorities in Japan’s Gifu prefecture have reported two fattening pigs have tested positive for classic swine fever (CSF) virus. This is Japan’s second reported case of CSF; the first case was found in the same prefecture in September. Officials said 43 wild boar of 324 caught in this area were positive for CSF between September 14 and November 14, 2018. (Animal Pharm)

• US – OPIOID AVAILABILITY The FDA announced that it has worked with Pfizer Inc. to help alleviate a shortage of certain injectable opioids available to treat pain in animals, by facilitating the availability of a limited amount of product labeled for human use. The FDA had already given Pfizer permission to import Hydromorphone Hydrochloride Injection to help alleviate the ongoing opioid shortage in human medicine. As a result of CVM’s recent discussion with Pfizer, this product is now available in limited quantities for pain management in animals. In addition to hydromorphone, Pfizer also has made Morphine Sulfate Injection, USP available to the U.S. veterinary market. (FDA)


Depend on Brakke Consulting to meet your company’s market research needs, whether it is:

• Assessing the feasibility of a new product or technology
• Identifying the opinions and trends of veterinarians, pet owners or producers
• Determining the current market for products

With our in-house database of veterinarians and the ability to custom-tailor surveys of a wide variety of target audiences, we provide reliable insights into this unique industry. We also produce multiclient reports in a number of high-interest animal health market areas. For more information, see our website or call our Dallas office at 972-243-4033.


I’ve been on the road this week visiting various clients and found that a number of senior managers have some vacation time left that they expect to utilize before year-end. This week a number of executives asked me if we would be having our 2019 Overview at VMX and WVC. The answer is yes, as indicated in the advertisement earlier in the newsletter. So we look forward to seeing many of you at our annual industry overview in Orlando and Las Vegas in 2019. We believe you and your management team will enjoy the changes we’ve made to this annual industry status report. Several companies have already booked their private presentations of the 2019 Overview to their management team.

Have a great weekend and HAPPY HOLIDAYS!

Ron Brakke

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at

en_USEnglish (United States)